Application no. and date | 19765421.3 (espacenet) (Federated) (European Patent Register), 20190828 | Patent/reg. no. and date | DK/EP 3843715, 20230913 | Publication date | 20210707 | Priority no. and date | EP 18191289, 20180828 | EP pub. no. and date |
EP 3843715 20210707 | Effective date | | Applicant/owner | Selo Medical GmbH, Moosham 29
5585 Unternberg, AT | Applicant ref. no. | | Inventor | FUCHS, Norbert, Moosham 29
5580 Unternberg, AT | Representative | | Opponent | | IPC Class | A61K 31/185 (2006.01) , A61K 31/19 (2006.01) , A61K 31/191 (2006.01) , A61K 33/04 (2006.01) , A61K 47/38 (2006.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) , A61P 31/12 (2006.01) | Title | THERAPY OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTIONS | Int. application no. | EP2019072926 | Int. publication no. | WO2020043762 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|